Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 5, 2007, Pages 904-910

  Al Joudi, Fawwaz Shakir ^a,c   Iskandar, Z A ^a   Imran, A K ^b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b General Hospital Kota Bharu   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35349023600     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Al-Joudi FS, Iskandar ZA, Samsudin AR. The effects of chemotherapeutic drugs on the viability, apoptosis and survivin expression in MCF-7 cells. Acta Histochem Cytochem 2005; 38: 323-30.
2. th ed. London: B.C. Decker, 2000.
3. Barbareschi M, Caffo O, Veronese S, et al. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol 1996; 27: 1149-55.
4. Campora GR, Ruiz GMR, Ramirez VF, et al. Apoptosis in breast carcinoma. Pathol Res Pract 2000; 196: 167-74.
5. Coultas L, Strasser A. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 2003; 13: 115-23.
6. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239-52.
7. Gursan N, Karakok M, Sari I, Gursan MS. The relationship between expression of p53/Bcl-2 and histopathological criteria in breast invasive ductal carcinomas. Int J Clin Pract 2001; 55: 589-90.
8. Hori M, Nogami T, Itabashi M, Yoshimi F, Ono H, Koizumi S. Expression of Bcl-2 in human breast cancer: correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis. Pathol Int 1997; 47: 757-62.
9. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256: 42-9.
10. Kavaselcuk F, Nursal TZ, Polat A, et al. Expression of survivin, bcl-2, p53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a). J Exp Clin Cancer Res 2004; 23: 105-12.
11. Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Acta 2002; 326: 27-45.
12. Levine AJ. p53, the cellular gatekeeper for the growth and division. Cell 1997; 88: 323-31.
13. Li YY, Li XM. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 2000; 10: 169-77.
14. Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. J Am Coll Surg 2004; 198: 83-90.
15. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58: 1808-12.
16. Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002; 21: 2613-22.
17. Norberg T, Klaar S, Lindqvist L, Lindahl T, Ahlgren J, Bergh J. Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers. Clin Chem 2001; 47: 821-8.
18. Ostrakhovitch EA, Cherian MG. Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc. Arch Biochem Biophys 2004; 423: 351-61.
19. Parton M, Dowsett M, Smith I. Studies of apoptosis in breast cancer. BMJ 2001; 322: 1528-32.
20. Pruschy MP, Rochia S, Zaugg K, et al. Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases. Int J Radiation Oncol Biol Phys 2001; 49: 561-7.
21. Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. Gene expression profiling revealed survivin as a target of 3,3′-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Res 2006; 66: 4952-60.
22. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941-53.
23. Sakaguchi K, Herrera JE, Saito S, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998; 12: 2831-41.
24. Sanna MC, da Silva Correla J, Ducrey O, et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspases inhibition. Mol Cell Biol 2002; 22: 1754-66.
25. Sharma K, Srikani CB. Induction of wild-type p53, bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cells. Int J Cancer 1998; 76: 259-66.
26. Shi ST, Yang GU, Wang LD, et al. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20: 591-7.
27. Shu S, Plautz GE, Krauss JC, Chang AE. Tumor immunology. JAMA 1997; 278: 1972-81.
28. Siziopikou KP, Schnitt SJ. MIB-1 proliferation index in ductal carcinoma in situ of the breast: relationship to the expression of the apoptosis-regulating proteins bcl-2 and p53. Breast J 2000; 6: 400-6.
29. Taylor WR, DePrimo SE, Agarwal A, et al. Mechanism of G2 arrest in response to overexpressionof p53. Mol Biol Cell 1999; 10: 3607-22.
30. Thomas LR. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 2000; 10: 245-66.
31. Tsutsui S, Yasuda K, Suzuki K, et al. Bcl-2 protein expression is associated with p27 and p53 protein expression and MIB-1 counts in breast cancer. SMC cancer 2006; 13: 187.
32. Vegran F, Boidot R, Oudin C, Detrain C, Rebucci M, Lizard-Nacol S. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 2007; 26: 290-7.
33. Zhou M, Gu L, Li F. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 2002; 303: 124-31.